Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

April 26, 2023 BIZ PEOPLE

Biohaven names physician to leadership team

PHOTO | CONTRIBUTED Dr. Nick Kozauer

New Haven-based biopharmaceutical company Biohaven Ltd. recently added Dr. Nick Kozauer to its executive leadership team.

Kozauer’s new role will be as senior vice president for clinical development and regulatory strategy.  

Kozauer previously worked at the U.S. Food and Drug Administration, where he served in multiple roles, most recently as director of the Division of Neurology 2 in the Office of New Drugs. 

At the FDA, Kozauer led the division responsible for the regulation of all investigational and new drug applications and biological licensing applications for drugs being developed to treat  neuroimmunologic conditions, epilepsy, migraine, stroke, traumatic brain injury and inner ear disorders.

Biohaven CEO Dr. Vlad Coric said Kozauer supervised and reviewed the approval of over 15 marketed drugs during his tenure at the FDA. 

“His knowledge and expertise in the regulatory process, as well as his deep experience in diseases including neuroimmunology and epilepsy, will only strengthen Biohaven's ability to efficiently advance our robust pipeline,” Coric said.

Sign up for Enews

Most Recent

Most Recent

0 Comments

Order a PDF